Fluadinazolam is a benzodiazepine derivative developed in 1973, with sedative and anxiolytic effects.[1] It is a derivative of the never commercially marketed benzodiazepine adinazolam and has similarly been sold as a designer drug.[2]
^US 3957761, Gall M, Hester JB, "Process for the production of 1-aminomethyl-6-phenyl-4h-s-triazolo-[4,3-a][1]benzodiazepines and intermediates", issued 18 May 1976, assigned to Pharmacia and Upjohn
^Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". Pharmaceuticals. 14 (8). Basel, Switzerland: 720. doi:10.3390/ph14080720. PMC 8398354. PMID 34451817.
Fluadinazolam is a benzodiazepine derivative developed in 1973, with sedative and anxiolytic effects. It is a derivative of the never commercially marketed...
controlled substance from 26 July 2023 to 26 July 2025. Clobromazolam Fluadinazolam Fluclotizolam Fludiazepam Flubromazolam Pyrazolam Flurazepam Triazolam...